During the past decade, Cardiovascular and Renal Research conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cardiovascular and Renal Research" #1 collaborator was "Danish Heart Foundation" with 1 trials as a collaborator, "Odense University Hospital" with 1 trials as a collaborator, "Region of Southern Denmark" with 1 trials as a collaborator, "The Ministry of Science, Technology and Innovation, Denmark" with 1 trials as a collaborator and "The University of Texas at Arlington" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Cardiovascular and Renal Research" are "Diabetic Nephropathies" (1 trials), "Endothelial Dysfunction" (1 trials), "Endothelium, Vascular" (1 trials), "Hypertension" (1 trials) and "Insulin Resistance" (1 trials). Many other conditions were trialed in "Cardiovascular and Renal Research" in a lesser frequency.

Most popular intervention types in "Cardiovascular and Renal Research" are "Drug" (4 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Amiloride" (1 trials), "BQ123" (1 trials), "BQ123 + BQ788" (1 trials), "Efonidipine" (1 trials) and "Eplerenone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cardiovascular and Renal Research" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Cardiovascular and Renal Research". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Cardiovascular and Renal Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Cardiovascular and Renal Research, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".